Increase expected in approved AI-based medical imaging products

by

The number of U.S. Food and Drug Administration (FDA)-approved artificial intelligence (AI) products is expected to increase from 69 in 2022 to 350 in 2035, according to a study published online Oct. 16 in the Journal of the American College of Radiology.

Leave A Comment

Your email address will not be published. Required fields are marked *